BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

235 related articles for article (PubMed ID: 7576443)

  • 1. Effect of manufacturing technology on the dissolution of ampicillin tablets.
    González M; Retaco P; Pizzorno MT; Volonté MG
    Boll Chim Farm; 1995 Sep; 134(8):448-53. PubMed ID: 7576443
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Investigation on drug dissolution and particle characteristics of pellets related to manufacturing process variables of high-shear granulation.
    Dévay A; Mayer K; Pál S; Antal I
    J Biochem Biophys Methods; 2006 Nov; 69(1-2):197-205. PubMed ID: 16650480
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of starch 1500 as a binder and disintegrant in lamivudine tablets prepared by high shear wet granulation.
    Rahman BM; Ibne-Wahed MI; Khondkar P; Ahmed M; Islam R; Barman RK; Islam MA
    Pak J Pharm Sci; 2008 Oct; 21(4):455-9. PubMed ID: 18930870
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Influence of adjuvants on the dissolution profile of tablets containing high doses of spray-dried extract of Maytenus ilicifolia.
    de Souza TP; Bassani VL; González Ortega G; dalla Costa TC; Petrovick PR
    Pharmazie; 2001 Sep; 56(9):730-3. PubMed ID: 11593994
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative study of different formulations of atenolol.
    Yasmeen R; Shoaib MH; Khalid H
    Pak J Pharm Sci; 2005 Jan; 18(1):47-51. PubMed ID: 16431383
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of processing technique of different dosage forms on dissolution rate of caffeine and salicylamide.
    Nerlo H; Czarnecki W; Dul R
    Pol J Pharmacol Pharm; 1976; 28(4):361-7. PubMed ID: 981026
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Enhancement of dissolution rate of piroxicam using liquisolid compacts.
    Javadzadeh Y; Siahi-Shadbad MR; Barzegar-Jalali M; Nokhodchi A
    Farmaco; 2005 Apr; 60(4):361-5. PubMed ID: 15848213
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High-amylose carboxymethyl starch matrices for oral sustained drug-release: in vitro and in vivo evaluation.
    Nabais T; Brouillet F; Kyriacos S; Mroueh M; Amores da Silva P; Bataille B; Chebli C; Cartilier L
    Eur J Pharm Biopharm; 2007 Mar; 65(3):371-8. PubMed ID: 17275270
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Multimodal approach to characterization of hydrophilic matrices manufactured by wet and dry granulation or direct compression methods.
    Kulinowski P; Woyna-Orlewicz K; Obrał J; Rappen GM; Haznar-Garbacz D; Węglarz WP; Jachowicz R; Wyszogrodzka G; Klaja J; Dorożyński PP
    Int J Pharm; 2016 Feb; 499(1-2):263-270. PubMed ID: 26752087
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development of an oral rutin nanocrystal formulation.
    Mauludin R; Müller RH; Keck CM
    Int J Pharm; 2009 Mar; 370(1-2):202-9. PubMed ID: 19114097
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Use of the crushing strength parameter for quality control of phenobarbital-microcrystalline cellulose tablets.
    Souto C; Gómez-Amoza JL; Landín M; Vila-Jato JL; Concheiro A; Martínez-Pacheco R
    Farmaco; 1989; 44(7-8):731-7. PubMed ID: 2590370
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Influence of the compression force on the dimension of particles of acetylsalicylic acid and their rapidity of dissolution].
    Cid E; Jaminet F
    Pharm Acta Helv; 1971 Mar; 46(3):167-78. PubMed ID: 5550120
    [No Abstract]   [Full Text] [Related]  

  • 13. Formulation and evaluation of dried yeast tablets using different techniques.
    Al-Mohizea AM; Ahmed MO; Al-jenoobi FI; Mahrous GM; Abdel-Rahman AA
    Eur J Pharm Biopharm; 2007 Aug; 67(1):253-9. PubMed ID: 17270410
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of hydrodynamic environment on tablet dissolution using flow-through dissolution apparatus.
    Wu Y; Ghaly ES
    P R Health Sci J; 2006 Mar; 25(1):75-83. PubMed ID: 16883682
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Thermoplastic granulation as an alternative method for the preparation of hydrophilic-lipophilic oral matriix tablets].
    Dvorácková K; Rabisková M; Masteiková R; Vocilková L
    Ceska Slov Farm; 2007 Jun; 56(3):129-34. PubMed ID: 17867525
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of drug physical form during granulation, tabletting and storage.
    Williams AC; Cooper VB; Thomas L; Griffith LJ; Petts CR; Booth SW
    Int J Pharm; 2004 May; 275(1-2):29-39. PubMed ID: 15081136
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Microcrystalline cellulose and their flow -- morphological properties modifications as an effective excpients in tablet formulation technology containing lattice established API and also dry plant extract].
    Zgoda MM; Nachajski MJ; Kołodziejczyk MK
    Polim Med; 2009; 39(1):17-30. PubMed ID: 19580170
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Continuous manufacturing of tablets with PROMIS-line - Introduction and case studies from continuous feeding, blending and tableting.
    Simonaho SP; Ketolainen J; Ervasti T; Toiviainen M; Korhonen O
    Eur J Pharm Sci; 2016 Jul; 90():38-46. PubMed ID: 26879237
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A comparative study of dissolution characteristics of polymeric and wax granulations of theophylline and their tablets.
    Uhumwangho MU; Okor RS
    Pak J Pharm Sci; 2008 Jul; 21(3):230-6. PubMed ID: 18614417
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterizing process effects on pharmaceutical solid forms using near-infrared spectroscopy and infrared imaging.
    Roggo Y; Jent N; Edmond A; Chalus P; Ulmschneider M
    Eur J Pharm Biopharm; 2005 Sep; 61(1-2):100-10. PubMed ID: 16005618
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.